Sarepta Therapeutics (SRPT) EBT Margin Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 48,476.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 441.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -408.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 7,297.00 |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn | 28,798.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28,798.00 |
| Dec 31, 2025 | -26,218.00 |
| Sep 30, 2025 | 7,482.00 |
| Jun 30, 2025 | 13,314.00 |
| Mar 31, 2025 | 18,564.00 |
| Dec 31, 2024 | 7,841.00 |
| Sep 30, 2024 | 3,257.00 |
| Jun 30, 2024 | 6,138.00 |
| Mar 31, 2024 | 12,395.00 |
| Dec 31, 2023 | 89,813.00 |
| Sep 30, 2023 | 86,310.00 |
| Jun 30, 2023 | 51,403.00 |
| Mar 31, 2023 | -7,087.00 |
| Dec 31, 2022 | 43,408.00 |
| Sep 30, 2022 | 391.00 |
| Jun 30, 2022 | 18,379.00 |
| Mar 31, 2022 | -38,530.00 |
| Dec 31, 2021 | 10,152.00 |
| Sep 30, 2021 | 7,290.00 |
| Jun 30, 2021 | 9,012.00 |
| Mar 31, 2021 | -5,940.00 |
| Dec 31, 2020 | -79,282.00 |
| Sep 30, 2020 | -77,360.00 |
| Jun 30, 2020 | -39,919.00 |
| Mar 31, 2020 | -65,819.00 |
| Dec 31, 2017 | 16.56 Mn |
| Sep 30, 2017 | 308,039.00 |
| Jun 30, 2017 | 99,155.00 |
| Mar 31, 2017 | 93,943.00 |